Arthur He CFA
Stock Analyst at H.C. Wainwright
(4.76)
# 631
Out of 5,073 analysts
134
Total ratings
46.2%
Success rate
24.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADAG Adagene | Reiterated: Buy | $7 | $2.41 | +190.46% | 20 | Oct 19, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $185 | $38.27 | +383.41% | 20 | Oct 2, 2026 | |
| IMA ImageneBio | Reiterated: Buy | $28 | $4.09 | +585.43% | 2 | Oct 1, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $55 | $15.13 | +263.52% | 7 | Oct 1, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | $8 | $3.81 | +109.97% | 19 | Oct 1, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $90 | $31.20 | +188.46% | 14 | Oct 1, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $25.31 | $9.52 | +165.89% | 15 | Sep 25, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $25 | $6.41 | +290.02% | 22 | Sep 14, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Buy | $17 | $16.90 | +0.59% | 3 | Feb 27, 2026 | |
| ADAPY Adaptimmune Therapeutics plc | Downgraded: Hold | n/a | $0.032 | n/a | 8 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.43 | n/a | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27.00 → $35.00 | $34.26 | n/a | 3 | Apr 3, 2023 |
Adagene
Oct 19, 2026
Reiterated: Buy
Price Target: $7
Current: $2.41
Upside: +190.46%
Nektar Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: $185
Current: $38.27
Upside: +383.41%
ImageneBio
Oct 1, 2026
Reiterated: Buy
Price Target: $28
Current: $4.09
Upside: +585.43%
Jade Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $55
Current: $15.13
Upside: +263.52%
Prime Medicine
Oct 1, 2026
Reiterated: Buy
Price Target: $8
Current: $3.81
Upside: +109.97%
Vera Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $90
Current: $31.20
Upside: +188.46%
Satellos Bioscience Inc.
Sep 25, 2026
Reiterated: Buy
Price Target: $25.31
Current: $9.52
Upside: +165.89%
Solid Biosciences
Sep 14, 2026
Reiterated: Buy
Price Target: $25
Current: $6.41
Upside: +290.02%
Aurinia Pharmaceuticals
Feb 27, 2026
Reiterated: Buy
Price Target: $17
Current: $16.90
Upside: +0.59%
Adaptimmune Therapeutics plc
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.032
Upside: n/a
Jun 21, 2024
Reiterated: Buy
Price Target: n/a
Current: $23.43
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $27.00 → $35.00
Current: $34.26
Upside: n/a